摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-2-(phenylthio)pyridine | 76700-38-4

中文名称
——
中文别名
——
英文名称
6-bromo-2-(phenylthio)pyridine
英文别名
(2-bromo-6-phenylthio)pyridine;2-bromo-6-phenylthiopyridine;2-Bromo-6-phenylsulfanylpyridine
6-bromo-2-(phenylthio)pyridine化学式
CAS
76700-38-4
化学式
C11H8BrNS
mdl
——
分子量
266.161
InChiKey
GXCVCXCIVJREKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.2
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-bromo-2-(phenylthio)pyridine间氯过氧苯甲酸 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 以42%的产率得到phenyl 6-bromopyridine-2-sulfone
    参考文献:
    名称:
    通过钯催化的芳基格氏试剂的交叉偶联合成取代的吡啶,喹啉和二嗪
    摘要:
    芳基卤化镁(苯基镁氯化物,间苯二甲氧基溴化镁,4-(甲氧基羰基)苯基氯化镁和4-氰基苯基氯化镁)与卤吡啶之间的钯催化交叉偶联反应可合成取代吡啶。由于使用了非常温和的条件(通常低于0°C),因此该反应可以扩展到使用功能化的卤代吡啶,卤代喹啉和卤代二嗪。
    DOI:
    10.1016/s0040-4020(02)00411-8
  • 作为产物:
    描述:
    二苯二硫醚异丙基氯化镁三乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 以49.9%的产率得到6-bromo-2-(phenylthio)pyridine
    参考文献:
    名称:
    PLATINUM COMPLEX AND LUMINESCENT ELEMENT
    摘要:
    公开号:
    EP1683804B1
点击查看最新优质反应信息

文献信息

  • Substituted pyridine methyl esters of naphthyl acids
    申请人:Zoecon Corporation
    公开号:US04223033A1
    公开(公告)日:1980-09-16
    Pyridyl esters and thiolesters of naphthyl acids, intermediates therefor, synthesis thereof and the use of said esters and thiolesters and compositions for the control of pests.
    吡啶酯和萘酸的硫醚酯,其中间体,其合成以及所述酯和硫醚酯的用途以及用于控制害虫的组合物。
  • Platinum complex and light emitting device
    申请人:Itoh Hisanori
    公开号:US20070103060A1
    公开(公告)日:2007-05-10
    Provision of a novel platinum complex which is useful as a material for a light-emitting device of good light emission characteristic and light emission efficiency, and a novel light-emitting material that may be utilized in various fields. A platinum complex represented by the following general formula (1): (in which two rings of ring A, ring B, ring C, and ring D represent nitrogen-containing heterocyclic rings which may have a substituent and the remaining two rings of them represent aryl rings or hetero aryl rings which may have a substituent, the ring A and the ring B, the ring A and the ring C or/and the ring B and the rind D may form condensed rings. Two of X 1 , X 2 , X 3 , and X 4 represent nitrogen atoms coordination bonded to a platinum atom and the remaining two of them represent carbon atoms or nitrogen atoms. Q 1 , Q 2 , and Q 3 each represents a bond, oxygen atom, sulfur atom or bivalent group, two of Z 1 , Z 2 , Z 3 , and Z 4 represent coordination bonds, and the remaining two of them represent covalent bonds, oxygen atoms or sulfur atoms), and a light-emitting device containing the platinum complex.
    提供了一种新型铂配合物,可用作具有良好发光特性和发光效率的发光器件材料,以及一种可用于各种领域的新型发光材料。该铂配合物由以下通式(1)表示:(其中环A、环B、环C和环D的两个环表示可能具有取代基的含氮杂环,其余两个环表示可能具有取代基的芳香环或杂芳香环,环A和环B、环A和环C或/和环B和环D可以形成融合环。X1、X2、X3和X4中的两个表示配位键结合到铂原子的氮原子,其余两个表示碳原子或氮原子。Q1、Q2和Q3各表示键合,氧原子,硫原子或二价基团,Z1、Z2、Z3和Z4中的两个表示配位键,其余两个表示共价键,氧原子或硫原子),以及含有该铂配合物的发光器件。
  • Polycyclic compounds as lysophosphatidic acid receptor antagonists
    申请人:Clark Ryan
    公开号:US08664220B2
    公开(公告)日:2014-03-04
    Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
    本文描述了一些能够拮抗赖氨酸磷酸受体的化合物。同时还描述了包括上述化合物的药物组成物和药物,以及使用这些拮抗剂的方法,单独或联合其他化合物,用于治疗依赖或介导赖氨酸磷酸的疾病或病症。
  • POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
    申请人:Clark Ryan
    公开号:US20130072490A1
    公开(公告)日:2013-03-21
    Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
    本文描述了一些是溶血磷脂酸受体拮抗剂的化合物。还描述了包括上述化合物的制药组合物和药物,以及使用这种拮抗剂的方法,单独或与其他化合物联合使用,用于治疗LPA依赖或LPA介导的疾病或疾病的方法。
  • HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
    申请人:SAMSUNG DISPLAY CO., LTD.
    公开号:US20180040833A1
    公开(公告)日:2018-02-08
    A heterocyclic compound and an organic light-emitting device including the heterocyclic compound, the heterocyclic compound being represented by the following Formula 1: A 1 -(A 2 ) n2 ,   wherein, in Formula 1, A 1 is a group represented by one of Formulae 2A and 2B, and A 2 is a group represented by Formula 3,
查看更多